Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » BOPA 2021 Symposium

BOPA 2021 Symposium

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 08/10/21 by Rajinder Nijjar

A collaborative audit on DPYD testing of all patients initiated on fluoropyrimidines (5-fluorouracil, capecitabine and oral prodrug tegafur) across 5 London teaching hospitals

Abstracts

View resources
Last reviewed: 08/10/21 by David Martin

An Evaluation of Nausea Amongst Patients Prescribed High Emetogenic Risk Chemotherapy

Abstracts

View resources
Last reviewed: 08/10/21 by John Leggett

An audit to investigate adherence to antibiotic prescribing in neutropenic sepsis guidelines in haemato-oncology and solid-oncology patients

Abstracts

View resources
Last reviewed: 08/10/21 by Rebecca Awre

Audit of zoledronic acid prescribing for multiple myeloma at North Bristol NHS Trust (NBT)

Abstracts

View resources
Last reviewed: 08/10/21 by Sanjay Popat

First-line nivolumab plus ipilimumab versus chemotherapy in unresectable malignant pleural mesothelioma (MPM) in CheckMate 743

Abstracts

View resources
Last reviewed: 08/10/21 by Bronwyn Cummings

Multiple Myeloma in the Elderly: An Irish Perspective

Abstracts

View resources
Last reviewed: 08/10/21 by Yatri Shah

Tolerability of Palbociclib plus aromatase inhibitor (AI) combination in women ≥75 years with oestrogen receptor positive (ER+ve), human epidermal growth factor receptor 2 negative (HER2-ve) advanced breast cancer at Mount Vernon Cancer Centre

Abstracts

View resources
Last reviewed: 08/10/21 by Natalia Czub

Audit of oral cryotherapy for the prevention of oral mucositis in patients undergoing chemotherapy containing high dose melphalan prior to autologous hematopoietic stem cell transplantation (HSCT)

Abstracts

View resources
Last reviewed: 08/10/21 by Yatri Shah

Real-world Adverse Event Data of the Avelumab plus Axitinib combination in Advanced Renal-cell Carcinoma

Abstracts

View resources
Last reviewed: 08/10/21 by Eoin Tabb

The occurrence of neutropenia despite primary prophylaxis with pegylated GCSF in adult patients undergoing myelosuppressive chemotherapy

Abstracts

View resources
Last reviewed: 08/10/21 by Tim Badcock

An Audit of the use of Treosulfan as part of a conditioning regimen prior to Allogeneic Haemopoietic Stem Cell Transplantation

Abstracts

View resources
Last reviewed: 08/10/21 by Kumud Kantilal

Facilitating healthcare practitioners to deliver self-management support in adult cancer survivors: a realist review

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 3 4 5 6 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.